Pharmacological doses of testosterone upregulated androgen receptor and 3-beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase and impaired leydig cells steroidogenesis in adult rats

Toxicological Sciences

Volumn 121, Issue 2, 2011, Pages 397-407

  Kostic, Tatjana S ^a   Stojkov, Natasa J ^a   Bjelic, Maja M ^a   Mihajlovic, Aleksandar I ^a   Janjic, Marija M ^a   Andric, Silvana A ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

3 HSD; Androgen receptor; Leydig cell; Steroidogenesis; Testosterone

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN RECEPTOR; AROMATASE; CARRIER PROTEIN; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYCLIC AMP; CYCLIC AMP PHOSPHODIESTERASE; CYTOCHROME P450 17; CYTOCHROME P450 17A1; LUTEINIZING HORMONE; PREGNENOLONE; PROGESTERONE; SCAVENGER RECEPTOR BI; STEROID DELTA ISOMERASE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TESTOSTERONE; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HORMONE ACTION; LEYDIG CELL; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; STEROIDOGENESIS; VIRILIZATION;

RATTUS;

EID: 79957834530     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr063     Document Type: Article

References (41)

1. Anderson, R. A., and Wu, F. C. (1996). Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone-enanatante. J. Clin. Endocrinol. Metab. 81, 896-901.
2. Andric, S. A., Janjic, M. M., Stojkov, N. J., and Kostic, T. S. (2007). Protein kinase G-mediated stimulation of basal Leydig cell steroidogenesis. Am. J. Physiol. Endocrinol. Metab. 293, E1399-E1408.
3. Andric, S. A., Janjic, M. M., Stojkov, N. J., and Kostic, T. S. (2010a). Sildenafil treatment in vivo stimulates Leydig cell steroidogenesis via cAMP and cGMP signaling pathway. Am. J. Physiol. Endocrinol. Metab. 299, E544-E550.
4. Andric, S. A., Janjic, M. M., Stojkov, N. J., and Kostic, T. S. (2010b). Testosterone-induced modulation of nitric oxide-cGMP signaling pathway and androgenesis in the rat Leydig cells. Biol. Reprod. 83, 434-442.
5. Bagatell, C. J., and Bremner, W. J. (1996). Androgens in men-uses and abuses. N. Engl. J. Med. 334, 707-714.
6. Bain, P. A., Yoo, M., Clarke, T., Hammond, S. H., and Payne, A. H. (1991). Multiple forms of mouse 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase and differential expression in gonads, adrenal glands, liver, and kidneys of both sexes. Proc. Natl. Acad. Sci. U.S.A. 88, 8870-8874.
7. Basaria, S. (2010). Androgen abuse in athletes: detection and consequences. J. Clin. Endocrinol. Metab. 95, 1533-1543.
8. Bhasin, S. (2010). The brave new world of function-promoting anabolic therapies: testosterone and frailty. J. Clin. Endocrinol. Metab. 95, 509-511.
9. Bhasin, S., Calof, O. M., Storer, T. W., Lee, M. L., Mazer, N. A., Jasuja, R., Montori, V. M., Gao, W., and Dalton, J. T. (2006). Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat. Clin. Pract. Endocrinol. Metab. 2, 146-159.
10. Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., and Casaburi, R. (1996). The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N. Engl. J. Med. 335, 1-7.
11. Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001). Testosterone dose-response relationships in healthy young men. Am. J. Physiol. Endocrinol. Metab. 281, E1172-E1181.
12. Burgos-Trinidad, M., Youngblood, G. L., Maroto, M. R., Scheller, A., Robins, D. M., and Payne, A. H. (1997). Repression of cAMP-induced expression of the mouse P450 17α-hydroxylase/C17-20 lyase gene (Cyp17) by androgens. Mol. Endocrinol. 11, 87-96.
13. Catt, K. J., and Dufau, M. L. (1973). Spare gonadotrophin receptors in rat testis. Nat. New Biol. 244, 219-221.
14. Clark, A. S., and Henderson, L. P. (2003). Behavioral and physiological responses to anabolic-androgenic steroids. Neurosci. Biobehav. Rev. 27, 413-436.
15. Clark, B. J., Wells, J., King, S. R., and Stocco, D. M. (1994). The purification, cloning, and expression of a novel luteinizing hormoneinduced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J. Biol. Chem. 269, 28314-28322.
16. Dufau, M. L. (1998). The luteinizing hormone receptor. Annu. Rev. Physiol. 60, 461-496.
17. Duschek, E. J. J., Gooren, L. J., and Netelenbos, C. (2004). Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men. Eur. J. Endocrinol. 150, 539-546.
18. Eacker, S. M., Agrawal, N., Qian, K., Dichek, H. L., Gong, E. Y., Lee, K., and Braun, R. E. (2008). Hormonal regulation of testicular steroid and cholesterol homeostasis. Mol. Endocrinol. 22, 623-635.
19. Hales, D. B., Sha, L. L., and Payne, A. H. (1987). Testosterone inhibits cAMPinduced de novo synthesis of Leydig cell cytochrome P-450(17a) by an androgen receptor-mediated mechanism. J. Biol. Chem. 262, 11200-11206.
20. Kanayama, G., Hudson, J. I., and Pope, H. G., Jr. (2010). Illicit anabolicandrogenic steroid use. Horm. Behav. 109, 6-13.
21. Kicman, A. T. (2008). Pharmacology of anabolic steroids. Br. J. Pharmacol. 154, 502-521.
22. Klover, P., Chen, W., Zhu, B. M., and Hennighausen, L. (2009). Skeletal muscle growth and fiber composition in mice are regulated through the transcription factors STAT5a/b: linking growth hormone to the androgen receptor. FASEB J. 23, 3140-3148.
23. Korenman S. G., Stevens, R. H., Carpenter, L. A., Robb, M., Niswender, G. D., Sherman, B. M. (1974). Estradiol radioimmunoassay without chromatography: procedure, validation and normal values. J. Clinical. Endocrinol. Metab. 38(4), 718-720.
24. Kostic, T. S., Stojkov, N. J., Janjic, M. M., and Andric, S. A. (2010). Structural complexity of the testis and PKG-I/StAR interaction regulate the Leydig cell adaptive response to repeated immobilization stress. Int. J. Androl. 33, 717-729.
25. Kostic, T. S., Stojkov, N. J., Janjic, M. M., Maric, D., and Andric, S. A. (2008). The adaptive response of adult rat Leydig cells to repeated immobilization stress: the role of protein kinase A and steroidogenic acute regulatory protein. Stress 11, 370-380.
26. Lavoie, H. A., and King, S. R. (2009). Transcriptional regulation of steroidogenic genes: STARD1, CYP11A1 and HSD3B. Exp. Biol. Med. (Maywood) 234(8), 880-907.
27. Martinez-Arguelles, D. B., and Papadopoulos, V. (2010). Epigenetic regulation of the expression of genes involved in steroid hormone biosynthesis and action. Steroids 75, 467-476.
28. Morelli, A., Filippi, S., Mancina, R., Luconi, M., Vignozzi, L., Marini, M., Orlando, C., Vannelli, G. B., Aversa, A., Natali, A., et al. (2004). Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 143, 2253-2263.
29. Mouriec, K., Gueguen, M. M., Manuel, C., Percevault, F., Thieulant, M. L., Pakdel, F., and Kah, O. (2009). Androgens upregulate cyp19a1b (aromatase B) gene expression in the brain of Zebrafish (Danio rerio) through estrogen receptors. Biol. Reprod. 80, 889-896.
30. Mu, X., Liu, K., Kleymenova, E., Sar, M., Young, S. S., and Gaido, K. W. (2006). Gene expression profiling of androgen receptor antagonists in the rat fetal testis reveals few common gene targets. J. Biochem. Mol. Toxicol. 20, 7-17.
31. Payne, A. H., and Hales, D. B. (2004). Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr. Rev. 25, 947-970.
32. Qamar, I., Park, E., Gong, E. Y., Lee, H. J., and Lee, K. (2009). ARR19 (androgen receptor corepressor of 19 kDa), an antisteroidogenic factor, is regulated by GATA-1 in testicular Leydig cells. J. Biol. Chem. 284, 18021-18032.
33. Shan, L., Hardy, D. O., Catterall, J. F., and Hardy, M. P. (1995). Effects of luteinizing hormone (LH) and androgen on steady state levels of messenger ribonucleic acid for LH receptors, androgen receptors and steroidogenic enzymes in rat Leydig cell progenitors in vivo. Endocrinology 136, 1686-1693.
34. Shi, Y., Schonemann, M. D., and Mellon, S. H. (2009). Regulation of P450c17 expression in the early embryo depends on GATA factors. Endocrinology 150, 946-956.
35. Simard, J., Ricketts, M. L., Gingras, S., Soucy, P., Feltus, F. A., and Melner, M. H. (2005). Molecular biology of the 3β-hydroxysteroiddehydrogenase/ D5-D 4 isomerase gene family. Endocr. Rev. 26, 525-582.
36. Sinha-Hikim, I., Taylor, W. E., Gonzalez-Cadavid, N. F., Zheng, W., and Bhasin, S. (2004). Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J. Clin. Endocrinol. Metab. 89, 5245-5255.
37. Stocco, D. M., Wang, X., Jo, Y., and Manna, P. R. (2005). Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought. Mol. Endocrinol. 19, 2647-2659.
38. Tan, S. H., Dagvadorj, A., Shen, F., Gu, L., Liao, Z., Abdulghani, J., Zhang, Y., Gelmann, E. P., Zellweger, T., Culig, Z., et al. (2008). Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells. Cancer. Res. 68, 236-248.
39. van Amsterdam, J., Opperhuizen, A., and Hartgens, F. (2010). Adverse health effects of anabolic-androgenic steroids. Regul. Toxicol. Pharmacol. 57, 117-123.
40. Wang, R. S., Tzeng, S. C. R., and Chang, C. (2009). Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice. Endocrinol. Rev. 30, 119-132.
41. Zhang, Y., and Dufau, M. L. (2003). Dual mechanisms of regulation of transcription of luteinizing hormone receptor gene by nuclear orphan receptors and histone deacetylasecomplexes. J. Steroid Biochem. Mol. Biol. 85, 401-414.